Summer Road LLC 的 Form 4 申報
Ocular Therapeutix, Inc（OCUL），2024/2/27 申報
- 申報編號
- 0000893838-24-000022
- 申報時間
- 2024/2/27
- 交易日
- 2024/2/26
- 申報延遲
- 1 天
- 10b5-1 計畫
- 沒有勾選
這份申報列了 1 筆非衍生性交易。公開市場買進合計 $700.0 萬。交易後 1 天申報。
申報人
一份 Form 4 可以有好幾位申報人，例如本人與他控制的基金。各交易表上顯示的是第一位。
| 申報人 | 與公司的關係 |
|---|---|
| Summer Road LLCCIK 0001604873 | 持股 10% 以上大股東 |
非衍生性證券（表 I）
普通股等股票的取得與處分，每一列是申報上的一筆。
| 交易日 | 證券 | 交易 | 股數 | 價格 | 金額 | 交易後持股 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2024/2/26 | Common Stock, $0.0001 par value per share | P買進取得 | +930,851 | $7.52F1 | +$6,999,999.52 | 8,591,401 | 間接 |
附註與備註
本站收錄交易價格引用的附註、修正申報（Form 4/A）的全部附註，以及申報的備註。其他附註，例如間接持有的方式、交易計畫的細節，請看 SEC EDGAR 上的原文。
- F1
These shares of Common Stock, $0.0001 par value per share (the "Common Stock"), were purchased by the Reporting Person at a price of $7.52 per share (the "Acquired Shares") through a private placement that closed on February 26, 2024 (the "Private Placement"), pursuant to a Securities Purchase Agreement, dated February 21, 2024, a copy of which was filed as Exhibit 10.1 to the Issuer's Form 8-K filed with the Securities and Exchange Commission (the "SEC") on February 22, 2024. In connection with the Private Placement, the Reporting Person also entered into a Registration Rights Agreement, dated February 21, 2024, a copy of which was filed as Exhibit 10.2 to the Issuer's Form 8-K filed with the SEC on February 22, 2024, pursuant to which the Issuer agreed to register for resale the Acquired Shares no later than 30 days following the closing of the Private Placement.
表 I 有 1 筆交易的價格引用這則附註。